German Firm Buys 15 Consumer Healthcare Brands From Gsk A german company is buying 15 consumer healthcare brands from glaxosmithkline (gsk). image courtesy of gsk german pharmaceutical firm stada ag entered into an agreement to purchase 15 of glaxosmithkline ’s (gsk) local and regional consumer healthcare brands, expanding its portfolio of otc products, a company announcement said monday. Private equity backed generic drugmaker stada said it has agreed to buy 15 consumer healthcare products from british drugmaker glaxosmithkline to further strengthen its prescription free drugs business in europe. stada agreed to pay more than 300 million euros ($325 million) according to two people familiar with the transaction. stada and gsk declined to comment on the price.
Gsk And Pfizer To Merge Consumer Healthcare Brands Pr Week Germany based stada has agreed to buy a portfolio of 15 consumer healthcare brands from glaxosmithkline (gsk) in european countries, including germany, france, poland, italy, russia, spain and switzerland. financial details of the deal have not been disclosed. Frankfurt, germany based generic drugmaker stada is buying 15 consumer healthcare products from uk’s glaxosmithkline. according to two sources familiar with the deal, stada is paying more than $325 million. gsk has combined its over the counter (otc) products division with pfizer’s to focus on global brands. stada, however, wants to expand its portfolio of smaller, national products. the. Bad vilbel, february 24, 2020 – stada ag is significantly expanding its global otc business agreeing to acquire a portfolio of well established local and regional consumer healthcare brands from glaxosmithkline (gsk) in countries predominantly in europe including france, germany, italy, poland, russia, spain and switzerland. By carlo martuscelli german pharmaceutical business stada arzneimittel ag said monday that it is acquiring a portfolio of consumer health care brands from glaxosmithkline for an undisclosed amo.
Gsk Consumer Healthcare Bad vilbel, february 24, 2020 – stada ag is significantly expanding its global otc business agreeing to acquire a portfolio of well established local and regional consumer healthcare brands from glaxosmithkline (gsk) in countries predominantly in europe including france, germany, italy, poland, russia, spain and switzerland. By carlo martuscelli german pharmaceutical business stada arzneimittel ag said monday that it is acquiring a portfolio of consumer health care brands from glaxosmithkline for an undisclosed amo. The german company bought five consumer skincare brands and pediatric cough liquids tixylix from gsk in a deal announced in june, about half a year after the gsk pfizer consumer merger became public. Private equity backed generic drugmaker stada <stagn.d> said it has agreed to buy 15 consumer healthcare products from british drugmaker glaxosmithkline <gsk.l> to further strengthen its prescription free drugs business in europe. stada agreed to pay more than 300 million euros ($325 million) according to two people familiar with the transaction. stada and gsk declined to comment on the price.
Gsk Consumer Healthcare Capital Markets Day Gsk The german company bought five consumer skincare brands and pediatric cough liquids tixylix from gsk in a deal announced in june, about half a year after the gsk pfizer consumer merger became public. Private equity backed generic drugmaker stada <stagn.d> said it has agreed to buy 15 consumer healthcare products from british drugmaker glaxosmithkline <gsk.l> to further strengthen its prescription free drugs business in europe. stada agreed to pay more than 300 million euros ($325 million) according to two people familiar with the transaction. stada and gsk declined to comment on the price.